Device
Superficial hyperthermia
Superficial hyperthermia is a medical device with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
67%
Ph phase_2
1
33%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Terminated(1)
Detailed Status
Completed1
Recruiting1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (33.3%)
N/A2 (66.7%)
Trials by Status
completed133%
recruiting133%
withdrawn133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingnot_applicable
Thermotherapy in Addition to SOC Palliative Radiotherapy
NCT06659146
withdrawnphase_2
Heat-Activated Target Therapy of Local-Regional Relapse in Breast Cancer Patients
NCT02850419
completednot_applicable
Deep Versus Superficial Heating in Patients With Knee Osteoarthritis
NCT01343147
Clinical Trials (3)
Showing 3 of 3 trials
NCT06659146Not Applicable
Thermotherapy in Addition to SOC Palliative Radiotherapy
NCT02850419Phase 2
Heat-Activated Target Therapy of Local-Regional Relapse in Breast Cancer Patients
NCT01343147Not Applicable
Deep Versus Superficial Heating in Patients With Knee Osteoarthritis
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3